Skip to content
Newsroom

Announcements and updates

Stay informed with the latest news and updates from our team. Discover recent developments, strategic insights, and key accomplishments in our ongoing efforts to support growth and innovation.

Corporate Finance

Bergs Securities acted as joint bookrunner in connection with the SEK 54m rights issue in Nanologica

Bergs Securities acted as joint bookrunner in connection with the SEK 54m rights issue in Nanologica

Corporate Finance
Bergs Securities acted as sole global coordinator in connection with the SEK 27m rights issue in Enzymatica
1 2
Skip to navigation